David T. Rubin

About

David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Professor of Pathology, Chief of the Section of Gastroenterology, Hepatology & Nutrition, and Director of the Inflammatory Bowel Disease Center at the University of Chicago Medicine. He earned his medical degree with honors from The University of Chicago Pritzker School of Medicine, where he also completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics. Rubin is an associate faculty member at the MacLean Center for Clinical Medical Ethics, an associate investigator at the University of Chicago Comprehensive Cancer Center, and a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He has served as the immediate past Chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation and is the current Chair of the International Organization for the Study of IBD. His research focuses on disease modification in inflammatory bowel disease (IBD), including clinical trial designs, novel measures of inflammation, prevention of adverse outcomes, and quality of life in IBD. Rubin has received multiple awards for his clinical research and contributions to the field, including the Sherman Prize for Excellence in Crohn’s and Colitis, the UChicago Michael Reese Lectureship Award, and the Arthur H. Rubenstein Mentorship in Academic Medicine Award. He is also the Editor-in-Chief of the ACG On-Line Education Universe…

Research topics

• Internal medicine
• Medicine
• Gastroenterology
• Intensive care medicine
• Surgery
• Physical therapy
• Computer Science
• Immunology
• Biology
• Physical medicine and rehabilitation

Selected publications

• STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

  Gastroenterology · 2021 · 2570 citations

  DOI

• Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management

  Gastroenterology · 2021 · 795 citations

  Senior authorCorresponding
  DOI

• Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

  The Lancet · 2022 · 373 citations

  DOI

• AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary

  Gastroenterology · 2020 · 233 citations

  1st authorCorresponding
  DOI

• Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry

  Gastroenterology · 2020 · 199 citations

  DOI

Frequent coauthors

• Joel Pekow

  University of Chicago

  182 shared

• Laurent Peyrin‐Biroulet

  Université de Lorraine

  174 shared

• David Choi

  University of Chicago

  174 shared

• Julián Panés

  Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

  173 shared

• Remo Panaccione

  165 shared

• Séverine Vermeire

  162 shared

• Russell D. Cohen

  158 shared

• Silvio Danese

  Vita-Salute San Raffaele University

  156 shared

Labs

• Rubin LabPI

Education

• M.D.

  University of Chicago Pritzker School of Medicine

  1994

• Other, Internal Medicine

  University of Chicago Pritzker School of Medicine

  1997

• Other, Gastroenterology

  University of Chicago Pritzker School of Medicine

  2001

• B.S., Honors Biology

  University of Illinois

  1990

Awards & honors

• ACG’s Governor’s Award of Excellence in Clinical Research (2…
• Sherman Prize for Excellence in Crohn’s and Colitis (2020)
• UChicago Michael Reese Lectureship Award (2023)
• Arthur H. Rubenstein Mentorship in Academic Medicine Award (…

Similar researchers at University of Chicago

• Eugene B. Changh-95